SCHEMBL8290925

SCHEMBL8290925

Cc1ccc(-c2ccccc2CN(C)C)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 15/20 0.49
▸ CYP1A2 P05177 15/20 0.49
▸ CYP3A4 P08684 10/20 0.49
▸ CLK4 Q9HAZ1 5/20 0.49
▸ ALDH1A1 P00352 9/20 0.48
▸ CYP2C19 P33261 5/20 0.48
▸ HPGD P15428 3/20 0.48
▸ GLA P06280 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HSD17B10 Q99714 7/20 0.47
▸ TDP1 Q9NUW8 2/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ TSHR P16473 1/20 0.45
▸ SLC6A2 P23975 4/20 0.45
▸ SLC6A4 P31645 4/20 0.45
▸ SLC6A3 Q01959 4/20 0.45
▸ MAPT P10636 1/20 0.43
▸ ALOX15 P16050 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290926 0.83 CYP1A2 (0.49) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL8279412 0.80 DPP4 (0.53) CYP1A2CYP2C19
SCHEMBL17888364 0.79 KCNA5 (0.55) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL6772767 0.78 SLC6A4 (0.53) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL743498 0.76 CYP1A2 (0.43) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL28102007 0.76 CYP1A2 (0.47) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL3464186 0.75 DPP4 (0.54) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
Bromide SCHEMBL27653706 0.73 DPP4 (0.52) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
Hydrochloric Acid SCHEMBL6048562 0.73 DPP4 (0.52) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1
SCHEMBL6048563 0.73 SLC6A4 (0.54) CYP2D6CYP1A2CYP3A4CLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005032490-A2 CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-14 — — WO disclosed
Send feedback